Veterinary Reference Laboratory Market worth $6.6 billion by 2026 - Exclusive Report by MarketsandMarkets™

·5 min read

CHICAGO, Dec. 3, 2021 /PRNewswire/ -- According to the new market research report "Veterinary Reference Laboratory Market by Service Type (Clinical Chemistry, Hematology, Immunodiagnostics, Molecular Diagnostics, Urinalysis), Application (Pathology, Bacteriology, Virology, Parasitology), Animal, and Region - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 6.6 billion by 2026 from USD 3.8 billion in 2021, at a CAGR of 11.0% during the forecast period.

Markets and Markets
Markets and Markets

Browse in-depth TOC on "Veterinary Reference Laboratory Market"
181 – Tables
54 – Figures
260 – Pages

Download PDF Brochure:

The Factors such as the growth in the companion animal population, rising demand for pet insurance, an increasing number of veterinary practitioners in developed economies, increasing demand for animal-derived food products, and increasing incidence of transboundary and zoonotic diseases are driving the growth of this market. However, growing pet care costs and the increasing demand for POC testing and portable instruments are restraining the growth of this market to some extent.

By Service type, the immunodiagnostic services segment is expected to account for the largest share of the market.

The immunodiagnostic services segment accounted for the largest share of the veterinary reference laboratory market. The large share of this segment can primarily be attributed to the widespread popularity of immunodiagnostics for disease diagnosis, screening of disease progression, and observing patient response to therapy.

On the basis of application, clinical pathology segment is expected to account for the largest share of the veterinary reference laboratory market.

The clinical pathology segment accounted for the largest share of the market in 2020. The rising volume of pathology tests performed is the major factor driving the demand for diagnostic products and consumables for clinical pathology applications.

On the basis of animal type, the companion animals segment is expected to account for the largest share of the veterinary reference laboratory market.

The companion animals accounted for the largest share of the market. This segment is also projected to register the highest CAGR during the forecast period. The large share and high growth rate of this segment are largely attributed to the growing adoption of companion animals, increasing disposable incomes, growing willingness of companion animal owners to spend more on animal health, and increasing incidence of zoonotic diseases.

Request Sample Pages:

North America to dominate the veterinary reference laboratory market during the forecast period.

North America accounted for the largest share of the market in 2020. The growth of the North American market can be attributed to the increasing adoption of companion animals, the growing pet insurance industry, rising veterinary healthcare expenditure, and the growing number of veterinary practices. In addition, a majority of players in the market are based in the US.

Prominent players in the Veterinary Reference Laboratory Market are IDEXX Laboratories, Inc. (US), VCA, Inc. (US), GD Animal Health (Netherlands), Boehringer Ingelheim (Germany), Zoetis Inc. (US), NEOGEN Corporation (US), LABOKLIN GmbH (Germany), SYNLAB International GmbH (Germany), Heska Corporation (US), Virbac (US) and Thermo Fisher Scientific, Inc. (US).

Speak to Analyst:

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Browse Related Reports:

Companion Animal Diagnostics Market by Technology (Immunodiagnostic, Clinical Biochemistry, Hematology, Urine Analysis), Application (Clinical Pathology, Virology, Bacteriology, Parasitology), Animal (Dog, Cat, Horse), End-User - Global Forecast to 2025

Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics (Lateral Flow Assays, ELISA), Molecular Diagnostics), Animal (Companion, Farm), Pathogen (Bacteria, Viral, Parasite), Enduser (Lab, Hospital, Clinics, PoC) - Forecast to 2024

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Research Insight:
Visit Our Web Site:
Content Source:


View original content:

SOURCE MarketsandMarkets

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting